North America Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Product Type (Drugs, and Devices), By End User (Hospitals, and Specialty Clinics), By Country and Growth Forecast, 2024

List of Tables

The North America Peripheral Artery Disease Market would witness market growth of 6.2% CAGR during the forecast period (2024-2031).

The US market dominated the North America Peripheral Artery Disease Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,877.5 million by 2031. The Canada market is experiencing a CAGR of 8.2% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7.6% during (2024 - 2031).

There are a number of important elements that are driving the industry, one of the most notable of which is the rising incidence of the condition. The prevalence rates of PAD are much higher with increasing age, as indicated by the National Library of Medicine, which estimates that nearly 8.5 million people in the United States alone are affected by the condition. This growing incidence is closely linked to the aging population. As people age, the likelihood of developing PAD increases due to the cumulative effects of risk factors such as hypertension, diabetes, high cholesterol, and smoking.

Another critical driver of the market is the rising prevalence of diabetes and hypertension, both of which are significant risk factors for the disease. These conditions exacerbate the risk of developing PAD, thereby increasing the patient pool requiring medical intervention. In addition, the increasing prevalence of lifestyle-related risk factors, including sedentary behavior and poor dietary practices, is a contributing factor to the increase in PAD cases.

In Canada, the demand for PAD treatment is influenced by an aging population and rising rates of diabetes. Statistics Canada highlights that the population aged 65 and over was 7,568,308 in July 2023. This demographic shift increases the prevalence of age-related conditions, including PAD. Furthermore, Diabetes Canada reports that 11 million Canadians are living with diabetes or prediabetes, conditions that significantly increase the risk of developing PAD. Moreover, in Mexico, the rising demand for PAD treatment is primarily driven by increasing rates of diabetes and obesity, coupled with a growing awareness of cardiovascular diseases. Diabetes in Mexico is increasing rapidly, with a prevalence of nearly 17% in 2021, as reported by the International Diabetes Federation. This implies that 14 million Mexican adults aged 20 to 79, or one in six individuals, are affected by diabetes. By 2045, it is anticipated that the condition will impact more than 21 million individuals. Thus, the North American market is projected for continued growth, propelled by the aforementioned factors.

Based on Product Type, the market is segmented into Drugs (Antiplatelet Medicines, Statins, Anti Hypertensive Medication, and Others), and Devices (Peripheral Stents, Peripheral Angioplasty Balloons, Peripheral Catheters, Plaque Modification Devices, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, and Peripheral Accessories). Based on End User, the market is segmented into Hospitals, and Specialty Clinics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Becton, Dickinson and Company
Bayer AG
Koninklijke Philips N.V.
Abbott Laboratories
Terumo Corporation
B. Braun Melsungen AG
Medtronic PLC
Boston Scientific Corporation
Cardinal Health, Inc.
Biotronik SE & Co. KG

North America Peripheral Artery Disease Market Report Segmentation

By Product Type

Drugs
- Antiplatelet Medicines
- Statins
- Anti Hypertensive Medication
- Others
Devices
- Peripheral Stents
- Peripheral Angioplasty Balloons
- Peripheral Catheters
- Plaque Modification Devices
- Inferior Vena Cava Filters
- Hemodynamic Flow Alteration Devices
- Peripheral Accessories

By End User

Hospitals
Specialty Clinics

By Country

US
Canada
Mexico
Rest of North America

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Peripheral Artery Disease Market, by Product Type
- 1.4.2 North America Peripheral Artery Disease Market, by End User
- 1.4.3 North America Peripheral Artery Disease Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. North America Peripheral Artery Disease Market by Product Type

4.1 North America Drugs Market by Region
4.2 North America Peripheral Artery Disease Market by Drugs Type
- 4.2.1 North America Antiplatelet Medicines Market by Country
- 4.2.2 North America Statins Market by Country
- 4.2.3 North America Anti Hypertensive Medication Market by Country
- 4.2.4 North America Others Market by Country
4.3 North America Devices Market by Region
4.4 North America Peripheral Artery Disease Market by Devices Type
- 4.4.1 North America Peripheral Stents Market by Country
- 4.4.2 North America Peripheral Angioplasty Balloons Market by Country
- 4.4.3 North America Peripheral Catheters Market by Country
- 4.4.4 North America Plaque Modification Devices Market by Country
- 4.4.5 North America Inferior Vena Cava Filters Market by Country
- 4.4.6 North America Hemodynamic Flow Alteration Devices Market by Country
- 4.4.7 North America Peripheral Accessories Market by Country

Chapter 5. North America Peripheral Artery Disease Market by End User

5.1 North America Hospitals Market by Country
5.2 North America Specialty Clinics Market by Country

Chapter 6. North America Peripheral Artery Disease Market by Country

6.1 US Peripheral Artery Disease Market
- 6.1.1 US Peripheral Artery Disease Market by Product Type
  - 6.1.1.1 US Peripheral Artery Disease Market by Drugs Type
  - 6.1.1.2 US Peripheral Artery Disease Market by Devices Type
- 6.1.2 US Peripheral Artery Disease Market by End User
6.2 Canada Peripheral Artery Disease Market
- 6.2.1 Canada Peripheral Artery Disease Market by Product Type
  - 6.2.1.1 Canada Peripheral Artery Disease Market by Drugs Type
  - 6.2.1.2 Canada Peripheral Artery Disease Market by Devices Type
- 6.2.2 Canada Peripheral Artery Disease Market by End User
6.3 Mexico Peripheral Artery Disease Market
- 6.3.1 Mexico Peripheral Artery Disease Market by Product Type
  - 6.3.1.1 Mexico Peripheral Artery Disease Market by Drugs Type
  - 6.3.1.2 Mexico Peripheral Artery Disease Market by Devices Type
- 6.3.2 Mexico Peripheral Artery Disease Market by End User
6.4 Rest of North America Peripheral Artery Disease Market
- 6.4.1 Rest of North America Peripheral Artery Disease Market by Product Type
  - 6.4.1.1 Rest of North America Peripheral Artery Disease Market by Drugs Type
  - 6.4.1.2 Rest of North America Peripheral Artery Disease Market by Devices Type
- 6.4.2 Rest of North America Peripheral Artery Disease Market by End User

Chapter 7. Company Profiles

7.1 Becton, Dickinson, and Company
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 SWOT Analysis
7.2 Bayer AG
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expense
- 7.2.5 SWOT Analysis
7.3 Koninklijke Philips N.V.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expense
- 7.3.5 Recent strategies and developments:
  - 7.3.5.1 Acquisition and Mergers:
- 7.3.6 SWOT Analysis
7.4 Abbott Laboratories
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expense
- 7.4.5 Recent strategies and developments:
  - 7.4.5.1 Acquisition and Mergers:
- 7.4.6 SWOT Analysis
7.5 Terumo Corporation
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expenses
- 7.5.5 Recent strategies and developments:
  - 7.5.5.1 Product Launches and Product Expansions:
- 7.5.6 SWOT Analysis
7.6 B. Braun Melsungen AG
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expenses
- 7.6.5 SWOT Analysis
7.7 Medtronic PLC
- 7.7.1 Company overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expenses
- 7.7.5 Recent strategies and developments:
  - 7.7.5.1 Acquisition and Mergers:
- 7.7.6 SWOT Analysis
7.8 Boston Scientific Corporation
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Segmental and Regional Analysis
- 7.8.4 Research & Development Expense
- 7.8.5 Recent strategies and developments:
  - 7.8.5.1 Acquisition and Mergers:
- 7.8.6 SWOT Analysis
7.9 Cardinal Health, Inc.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 SWOT Analysis
7.10. Biotronik SE & Co. KG
- 7.10.1 Company Overview
- 7.10.2 SWOT Analysis

LIST OF TABLES

TABLE 1 North America Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 2 North America Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 3 North America Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 4 North America Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 5 North America Drugs Market by Region, 2020 - 2023, USD Million
TABLE 6 North America Drugs Market by Region, 2024 - 2031, USD Million
TABLE 7 North America Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 8 North America Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 9 North America Antiplatelet Medicines Market by Country, 2020 - 2023, USD Million
TABLE 10 North America Antiplatelet Medicines Market by Country, 2024 - 2031, USD Million
TABLE 11 North America Statins Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Statins Market by Country, 2024 - 2031, USD Million
TABLE 13 North America Anti Hypertensive Medication Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Anti Hypertensive Medication Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Devices Market by Region, 2020 - 2023, USD Million
TABLE 18 North America Devices Market by Region, 2024 - 2031, USD Million
TABLE 19 North America Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 20 North America Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 21 North America Peripheral Stents Market by Country, 2020 - 2023, USD Million
TABLE 22 North America Peripheral Stents Market by Country, 2024 - 2031, USD Million
TABLE 23 North America Peripheral Angioplasty Balloons Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Peripheral Angioplasty Balloons Market by Country, 2024 - 2031, USD Million
TABLE 25 North America Peripheral Catheters Market by Country, 2020 - 2023, USD Million
TABLE 26 North America Peripheral Catheters Market by Country, 2024 - 2031, USD Million
TABLE 27 North America Plaque Modification Devices Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Plaque Modification Devices Market by Country, 2024 - 2031, USD Million
TABLE 29 North America Inferior Vena Cava Filters Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Inferior Vena Cava Filters Market by Country, 2024 - 2031, USD Million
TABLE 31 North America Hemodynamic Flow Alteration Devices Market by Country, 2020 - 2023, USD Million
TABLE 32 North America Hemodynamic Flow Alteration Devices Market by Country, 2024 - 2031, USD Million
TABLE 33 North America Peripheral Accessories Market by Country, 2020 - 2023, USD Million
TABLE 34 North America Peripheral Accessories Market by Country, 2024 - 2031, USD Million
TABLE 35 North America Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 36 North America Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 37 North America Hospitals Market by Country, 2020 - 2023, USD Million
TABLE 38 North America Hospitals Market by Country, 2024 - 2031, USD Million
TABLE 39 North America Specialty Clinics Market by Country, 2020 - 2023, USD Million
TABLE 40 North America Specialty Clinics Market by Country, 2024 - 2031, USD Million
TABLE 41 North America Peripheral Artery Disease Market by Country, 2020 - 2023, USD Million
TABLE 42 North America Peripheral Artery Disease Market by Country, 2024 - 2031, USD Million
TABLE 43 US Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 44 US Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 45 US Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 46 US Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 47 US Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 48 US Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 49 US Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 50 US Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 51 US Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 52 US Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 53 Canada Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 54 Canada Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 55 Canada Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 56 Canada Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 57 Canada Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 58 Canada Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 59 Canada Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 60 Canada Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 61 Canada Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 62 Canada Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 63 Mexico Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 64 Mexico Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 65 Mexico Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 66 Mexico Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 67 Mexico Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 68 Mexico Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 69 Mexico Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 70 Mexico Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 71 Mexico Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 72 Mexico Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 73 Rest of North America Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 74 Rest of North America Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 75 Rest of North America Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 76 Rest of North America Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 77 Rest of North America Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 78 Rest of North America Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 79 Rest of North America Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 80 Rest of North America Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 81 Rest of North America Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 82 Rest of North America Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 83 Key Information - Becton, Dickinson and Company
TABLE 84 Key Information - Bayer AG
TABLE 85 Key Information - Koninklijke Philips N.V.
TABLE 86 Key Information - Abbott Laboratories
TABLE 87 Key Information - Terumo Corporation
TABLE 88 Key Information - B. Braun Melsungen AG
TABLE 89 Key Information - Medtronic PLC
TABLE 90 Key Information - Boston Scientific Corporation
TABLE 91 key information - Cardinal Health, Inc.
TABLE 92 Key Information - Biotronik SE & Co. KG

North America Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Product Type (Drugs, and Devices), By End User (Hospitals, and Specialty Clinics), By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents